Belomeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 187,077 | 216,434 | 195,949 | 237,959 | 294,125 | 309,363 | 329,741 | 351,653 |
| Profit before tax | 524 | 32,181 | 49,517 | 34,234 | 54,127 | 48,945 | 45,921 | 57,638 |
| Net profit | 498 | 30,564 | 47,041 | 32,522 | 51,412 | 40,549 | 38,529 | 47,425 |
| Equity | 10,681 | 41,245 | 57,933 | 51,866 | 57,278 | 50,406 | 44,935 | 52,760 |
| Liabilities | 31,348 | 36,388 | 20,221 | 59,791 | 50,302 | 48,577 | 33,817 | 28,271 |
| Non-current assets | 8,621 | 49,262 | 46,094 | 65,088 | 53,370 | 41,898 | 31,255 | 21,617 |
| Current assets | 33,408 | 28,371 | 32,060 | 46,569 | 54,210 | 57,085 | 47,497 | 59,414 |
| Total assets | 42,029 | 77,633 | 78,154 | 111,657 | 107,580 | 98,983 | 78,752 | 81,031 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 30,914 | 45,243 | 42,108 |
| Social insurance contributions | - | - | - | - | - | 23,937 | 26,616 | 28,167 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +0.3% | +15.7% | -9.5% | +21.4% | +23.6% | +5.2% | +6.6% | +6.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.2% | 39.4% | 60.2% | 29.1% | 47.8% | 41.0% | 48.9% | 58.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.7% | 74.1% | 81.2% | 62.7% | 89.8% | 80.4% | 85.7% | 89.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.3% | 14.1% | 24.0% | 13.7% | 17.5% | 13.1% | 11.7% | 13.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.3% | 14.9% | 25.3% | 14.4% | 18.4% | 15.8% | 13.9% | 16.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.9 | 0.9 | 0.3 | 1.2 | 0.9 | 1.0 | 0.8 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 26,725 | 30,919 | 32,211 | 39,660 | 49,021 | 51,561 | 54,957 | 68,061 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Belomeda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-22 | 158.26 |
Belomeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-10-01 | 2024-10-16 | 1.22 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Belomeda, UAB (code 300002342) is a Private Limited Liability Company engaged in dental practice care activities. In 2025, the company generated revenue of €351.7K and net profit of €47.4K, giving a profit margin of 13.5%. Revenue increased by 6.7% year on year and by 13.7% over two years, showing a steady upward trend. Profitability also improved after a softer 2024, when net profit was €38.5K compared with €40.5K in 2023, before recovering to the latest result in 2025. The balance sheet remained compact, with total assets of €81.0K, equity of €52.8K and liabilities of €28.3K at the end of 2025. The equity ratio stood at 65.1% and debt-to-equity at 0.54, indicating moderate leverage. Asset turnover was 4.34x, reflecting efficient use of assets, while ROE of 89.9% and ROA of 58.5% point to strong returns in relation to the company’s capital base. Revenue per employee was €70.3K and profit per employee €9.5K.